Increase in tacrolimus trough levels after steroid withdrawal

Transplant International

Volumn 16, Issue 10, 2003, Pages 721-725

  Van Duijnhoven, Elly M ^a   Boots, Johannes M M ^a   Christiaans, Maarten H L ^a   Stolk, Leo M L ^a   Undre, Nasrullah A ^b   Van Hooff, Johannes P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Fujisawa Germany   (Germany)

Author keywords

Pharmacokinetics; Renal transplantation; Steroid withdrawal; Tacrolimus levels

Indexed keywords

CREATININE; CYTOCHROME P450 3A4; GLUCOCORTICOID; ISOENZYME; PREDNISOLONE; STEROID; TACROLIMUS;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG WITHDRAWAL; ENZYME INDUCTION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; AREA UNDER CURVE; DRUG INTERACTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; METABOLIC CLEARANCE RATE; NETHERLANDS; PREDNISOLONE; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 0242558148     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-003-0615-1     Document Type: Article

References (21)

1. Boots JMM, van Duijnhoven EM, Christiaans MHL, Wolffenbuttel BHR, van Hooff JP (2002) Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. JASN 13: 221-227
2. Boots JMM, van Duijnhoven EM, Christiaans MHL, Nieman FHM, van Suylen RJ, van Hooff JP (2001) Single center experience with tacrolimus versus cyclosporin-Neoral in renal transplant recipients. Transpl Int 14: 370-383
3. Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Strazl TE, Shapiro R (2000) Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus based immunosuppression. Transplantation 70: 760-764
4. Christiaans M, van Duijnhoven E, Beysens T, Undre N, Schäfer A, van Hooff J (1998) Effects of breakfast on the oral bioavailibility of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients. Transplant Proc 30: 1271-1273
5. Hricik DE, Kupin WL, First MR (1994) Steroid-free immunosuppression after renal transplantation. J Am Soc Nephrol [Suppl] 4: 10-16
6. Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE (2000) Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 69: 834-841
7. Lo A, Burckart GJ (1999) P-glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol 39: 995-1005
8. Mayer AD, Dmitrewski J, Squifflet JP, Bessen T, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RWG, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JLR, Talbot D, Neumayer HH, Hauser I, Ericzon BG, Brattström C, Claesson K, Mühlbacher F, Pohanka E (1997) Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 64: 436-443
9. Moochhala SM, Lee EJD, Earnest L, Wong JYY, Ngoi SS (1991) Inhibition of drug metabolism in rat and human liver microsomes by FK 506 and cyclosporine. Transplant Proc 23: 2786-2788
10. Omar G, Shah LA, Thomson AW, Whiting PH, Burke MD (1993) FK 506 inhibition of cyclosporine metabolism by human liver microsomes. Transplant Proc 23: 690-698
11. Oppenheimer F (2000) Steroid withdrawal in renal transplant recipients. Transplant Proc 32: 14-15
12. Piekoszewski W, Chow FS, Jusko WJ (1994) Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits. Pharmacol Exp Ther 269: 103-109
13. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 63: 977-983
14. Plosker GL (2000) Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 59: 323-389
15. Sattler M, Guengerich PF, Yun CH, Christians U, Sewing KF (1992) Cytochrome p-450 3A enzymes are responsible for biotransfromation of FK 506 and rapamycin in man and rat. Drug Metab Dispos 20: 753-761
16. Schulak JA, Hricik DE (1994) Steroid withdrawal after renal transplantation. Clin Transplant 8: 211-216
17. Sewing KF (1994) Pharmacokinetics, dosing principles and blood level monitoring of FK506. Transplant Proc 26: 3267-3269
18. Shah LA, Whiting PH, Omar G, Thomson AW, Burke MD (1991) Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. Transplant Proc 23: 2783-2785
19. Shapiro R, Jordan ML, Scantlebury VP (1995) The superiority of tacrolimus in renal transplant recipients the Pittsburgh experience. Clin Transpl 199-205
20. Tredger JM, Gilkes CD, Gonde CE (1999) Performance of the Imx tacrolimus II assay and practical limits of detection. Clin Chem 45: 1881-1882
21. Wallemacq PE, Leal T, Besse T, Squifflet J-P, Reding R, Otte J-B, Lerut J, Hassoun A (1997) Imx Tacrolimus II vs Imx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. Clin Chem 43: 1989-1991